Donnie Dunagan, MD
Allergy · Augusta, GANPI 1760438444
Payments from drug & device makers
Across 789 payments — averaging $23.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$4K
- AstraZeneca$3K
- Sanofi$2K
- Regeneron Healthcare Solutions, Inc.$2K
- Optinose US, Inc.$927
- CSL Behring$873
- plus $6K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 180 | $4,106 |
| AstraZeneca | 103 | $2,892 |
| Sanofi | 73 | $2,053 |
| Regeneron Healthcare Solutions, Inc. | 60 | $1,662 |
| Optinose US, Inc. | 45 | $927 |
| CSL Behring | 40 | $873 |
| Pfizer | 45 | $726 |
| Biocryst US Sales Co., LLC | 31 | $661 |
| Novartis | 25 | $586 |
| LEO Pharma Inc. | 16 | $423 |
| Grifols USA, LLC | 22 | $399 |
| Pharming Healthcare, Inc. | 15 | $347 |
| Sanofi-aventis U.S. LLC | 4 | $319 |
| Kaleo, Inc. | 19 | $305 |
| Galderma Laboratories, L.p. | 13 | $298 |
| Genentech USA, Inc. | 14 | $267 |
| Phathom Pharmaceuticals, Inc. | 4 | $253 |
| Teva Pharmaceuticals USA, Inc. | 19 | $181 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $176 |
| Octapharma USA, Inc. | 3 | $146 |
| Incyte Corporation | 6 | $128 |
| AbbVie | 5 | $116 |
| Hikma Pharmaceuticals USA | 7 | $114 |
| Boehringer Ingelheim | 6 | $105 |
| Lilly USA, LLC | 3 | $79 |
| Ionis Pharmaceuticals, Inc. | 3 | $75 |
| Cycle Pharmaceuticals Inc | 3 | $71 |
| Amgen | 4 | $66 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $58 |
| Dermavant Sciences, Inc. | 2 | $42 |
| Organon | 2 | $31 |
| ADMA Biomanufacturing LLC | 1 | $27 |
| USWM, LLC | 1 | $21 |
| Mylan Specialty L.p. | 1 | $20 |
| Shire North American Group Inc | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Merck | 1 | $13 |
How this compares
Too few allergy providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in Augusta
- Tesneem ChaudharyAugusta$6K
- Jaya TherattilAugusta$4K
- Thomas ChackoAlpharetta$63K
- Amy HirshAtlanta$14K
- Tricia LeeDecatur$13K
- Theodore LeeAtlanta$11K
- Anu MongiaCartersville$8K
- John HalwigAustell$5K
- Carol WigginsAtlanta$5K
- Ariana BuchananCarrollton$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.